NCT05094765 Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHD Status UNKNOWN Phase EARLY_PHASE1
NCT04945096 Outcomes of Patients After Allo-HSCT With Decitabine and NAC Status NOT_YET_RECRUITING Phase PHASE3
NCT03945591 High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Status COMPLETED Phase PHASE2
NCT03851601 Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis Status COMPLETED Phase N/A
NCT03763318 A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD Status COMPLETED Phase PHASE1/PHASE2
NCT03680092 Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT03605927 CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease Status COMPLETED Phase PHASE1
NCT03459040 A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD Status COMPLETED Phase PHASE2
NCT03233659 Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Status COMPLETED Phase N/A
NCT03188601 α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD Status COMPLETED Phase N/A
NCT02942173 CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT Status COMPLETED Phase PHASE2/PHASE3
NCT02891603 A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression Status COMPLETED Phase PHASE1/PHASE2
NCT02712762 Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients Status COMPLETED Phase N/A
NCT02588339 Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention Status COMPLETED Phase PHASE2
NCT02490163 Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC) Status COMPLETED Phase PHASE3
NCT02441075 70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014 Status COMPLETED Phase NA
NCT02338232 Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation Status TERMINATED Phase NA